Fostering collaborative research for rare genetic disease: The example of niemann-pick type C disease

Steven U. Walkley, Cristin D. Davidson, Jonathan Jacoby, Philip D. Marella, Elizabeth A. Ottinger, Christopher P. Austin, Forbes D. Porter, Charles H. Vite, Daniel S. Ory

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Rare disease represents one of the most significant issues facing the medical community and health care providers worldwide, yet the majority of these disorders never emerge from their obscurity, drawing little attention from the medical community or the pharmaceutical industry. The challenge therefore is how best to mobilize rare disease stakeholders to enhance basic, translational and clinical research to advance understanding of pathogenesis and accelerate therapy development. Here we describe a rare, fatal brain disorder known as Niemann-Pick type C (NPC) and an innovative research collaborative known as Support of Accelerated Research for NPC (SOAR-NPC) which illustrates one pathway through which knowledge of a rare disease and its possible treatments are being successfully advanced. Use of the "SOAR" mechanism, we believe, offers a blueprint for similar advancement for many other rare disorders.

Original languageEnglish (US)
Article number161
JournalOrphanet Journal of Rare Diseases
Issue number1
StatePublished - Jan 12 2016


  • Collaborative science
  • Cyclodextrin
  • Drug pipeline
  • Lysosomal disease
  • Miglustat
  • Niemann-Pick C
  • Patient advocacy
  • Rare disease
  • Therapy development
  • Translational medicine

ASJC Scopus subject areas

  • Genetics(clinical)
  • Pharmacology (medical)


Dive into the research topics of 'Fostering collaborative research for rare genetic disease: The example of niemann-pick type C disease'. Together they form a unique fingerprint.

Cite this